Council agenda

(d) The programme will be subject to review at the end of 2017.
C/16/20
Finances
C/16/20a
Management and governance letter
Council RECEIVED copies of the Management and Governance letter from the auditors
appertaining to the accounts for the period 1 October 2014-30 September 2016. The purpose of
the letter is to set out for Trustees/Directors the significant matters which came to the attention of
the auditors during the course of their audit of the financial statements of British Society for
Antimicrobial Chemotherapy (the “Charity”) for the year ended 30 September 2015. The auditors
were present on site to test accountancy systems and procedures from 16-18 February inclusive.
The letter was issued in accordance with the International Standard on Auditing (UK and Ireland)
260, Communication of audit matters.
Members were pleased to NOTE that there were no recommendations for improvement or items of
concern, significant or otherwise were noted or raised during the course of the audit.
C/16/20b
BSAC Resistance Surveillance Programme
The Honorary Treasurer reported that the financial position with regards to the BSAC Resistance
Surveillance Programme for the year 2016 had improved. Four sponsors have now signed for the
year 2016, reducing the overall project deficit to £25,664.95. The Standing Committee is
continuing to work on the business model to ensure the programme is cost-neutral, including
taking account of service costs provided by Southmead Hospital (salaries) from 2017 onwards.
C/16/21
Grants
Council:
(a)
APPROVED amendments to the criteria for applicants applying for BSAC grants. The criteria
for the 2016 call will read:
“BSAC encourages applications on topics consistent with the strategy of this Society, and
from early career researchers and clinical trainees. Furthermore, we support proof of
principle research projects which will facilitate applications to other funding agencies.
Please note that we do not encourage applications from those who have been in receipt of
total research funding of more than £100,000 (or equivalent currency of applicant’s
country) in the last 2 years.
6